drugset / Trial / NCT06345703
First-into-human Study of NS-136 in Healthy Subjects
RandomizedSequentialTriple-blindTreatment
Summary
The goal of this clinical trial is to exlplore the profile of NS-136 in health conditions. The main questions it aims to answer are: * Is NS-136 safe and tolerable in heathy subjects under tested dosing regimen? * What is the pharmacokinectic profile of NS-136 in healthy subjects under tested dosing regimen?
Timeline
- Start
- 2024-04-30
- Primary completion
- 2024-11
- Completion
- 2025-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NS-136 | Unknown | — | — |
Indications
No indication recorded.